173 related articles for article (PubMed ID: 3623015)
1. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B.
Shiels MT; Taswell HF; Czaja AJ; Nelson C; Swenke P
Gastroenterology; 1987 Oct; 93(4):675-80. PubMed ID: 3623015
[TBL] [Abstract][Full Text] [Related]
2. Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan.
Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
Gastroenterol Jpn; 1990 Oct; 25(5):593-7. PubMed ID: 2227250
[TBL] [Abstract][Full Text] [Related]
3. Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease?
Heijtink RA; van Hattum J; Schalm SW; Masurel N
J Med Virol; 1982; 10(2):83-90. PubMed ID: 6183398
[TBL] [Abstract][Full Text] [Related]
4. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of concurrent hepatitis B surface antigen and antibody positivity.
Tsang TK; Blei AT; O'Reilly DJ; Decker R
Dig Dis Sci; 1986 Jun; 31(6):620-4. PubMed ID: 3709326
[TBL] [Abstract][Full Text] [Related]
6. Concomitant hepatitis B surface antigen and antibody in thirteen patients.
Foutch PG; Carey WD; Tabor E; Cianflocco AJ; Nakamoto S; Smallwood LA; Gerety RJ
Ann Intern Med; 1983 Oct; 99(4):460-3. PubMed ID: 6625377
[TBL] [Abstract][Full Text] [Related]
7. Interplay of cell and serum immunologic markers in chronic persistent or active hepatitis B.
Picciotto A; Crovari P; Cuneo Crovari P; De Flora S; Dodero M; Celle G
J Med Virol; 1981; 8(3):195-200. PubMed ID: 7328423
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study.
Sobĕslavský O
Bull World Health Organ; 1980; 58(4):621-8. PubMed ID: 6969134
[TBL] [Abstract][Full Text] [Related]
10. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
11. High HBsAg and anti-delta carrier rate among asymptomatic Africans living on the campus of the University of Niamey, Niger.
Soubiran G; Le Bras M; Marini P; Sekou H
Trans R Soc Trop Med Hyg; 1987; 81(6):998-1000. PubMed ID: 3503422
[TBL] [Abstract][Full Text] [Related]
12. [Antigen e and its antibodies in acute serum hepatitis and in persons with a prolonged HBs-antigenemia].
Paktoris EA; Trofimova LI; Sergeeva NA; Sinaĭko GA; Shakhgil'dian IV
Vopr Virusol; 1979; (2):156-61. PubMed ID: 107654
[TBL] [Abstract][Full Text] [Related]
13. [The frequency of detecting antibodies to the delta antigen in virtually healthy HBsAg and anti-HBs carriers in Ulan-Bator].
Nimadava P; Anan'ev VA; Oiuunbileg Zh; Chernovetskiĭ MA
Vopr Virusol; 1988; 33(2):246-7. PubMed ID: 3414072
[No Abstract] [Full Text] [Related]
14. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
16. [ Subtypes of HBsAG in Morocco: general distribution in HBsAG carriers in Casablanca in terms of their clinical state. Relations with the markers of the HBe system].
Rioche M
Bull Soc Pathol Exot Filiales; 1986; 79(2):191-8. PubMed ID: 3089637
[TBL] [Abstract][Full Text] [Related]
17. Acute hepatitis B viral infection in a patient with anti-HBs.
Wang YJ; Lee SD; Wu JC; Lo KJ
J Med Virol; 1991 Oct; 35(2):133-5. PubMed ID: 1765776
[TBL] [Abstract][Full Text] [Related]
18. The surface antigen (HBsAg) and the e-antigen (HBeAg) in Somalian patients with acute viral hepatitis.
Nuti M; Harare O; Thamer G
Trans R Soc Trop Med Hyg; 1979; 73(2):185-7. PubMed ID: 473307
[TBL] [Abstract][Full Text] [Related]
19. Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience.
Shiels MT; Czaja AJ; Taswell HF; Gerin JL; Purcell RH; Ludwig J; Rakela J; Nelson CA
Gastroenterology; 1985 Dec; 89(6):1230-4. PubMed ID: 4054516
[TBL] [Abstract][Full Text] [Related]
20. A family infected with hepatitis B and with concurrently circulating HBsAg and heterotypic anti-HBs.
Thijs JC; van Bergeijk L; Heijtink RA; Douwes AC; Meuwissen SG
Hepatogastroenterology; 1984 Apr; 31(2):69-71. PubMed ID: 6724498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
